Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-10-04 Purchase | 2023-10-06 5:32 pm | Cadrenal Therapeutics Inc. | CVKD | MURPHY JOHN RAYMOND Director | 20,000 | $0.69867 | $13,973 | 614,792 (Direct) | View |
2023-09-05 Purchase | 2023-09-06 3:28 pm | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X CEO and Chairman 10% Owner | 40,000 | $0.9047 | $36,188 | 6,410,000 (Indirect Direct) | View |
2023-09-01 Purchase | 2023-09-05 06:05 am | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X CEO and Chairman 10% Owner | 70,000 | $0.9135 | $63,945 | 6,370,000 (Indirect Direct) | View |
2023-03-21 Purchase | 2023-03-22 4:01 pm | Cadrenal Therapeutics Inc. | CVKD | MURPHY JOHN RAYMOND Director | 10,000 | $1.39 | $13,900 | 594,792 (Direct) | View |
2023-03-16 Purchase | 2023-03-16 5:27 pm | Cadrenal Therapeutics Inc. | CVKD | MURPHY JOHN RAYMOND Director | 20,000 | $1.6699 | $33,398 | 574,792 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-04-10 Gift | 2024-04-10 5:30 pm | N/A N/A | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X CEO and Chairman 10% Owner | 50,000 | $0 | 6,275,000 (Direct) | View |
2024-04-02 Option Award | 2024-04-03 5:21 pm | 2025-04-01 2034-04-01 | Cadrenal Therapeutics Inc. | CVKD | Cole Jeffrey Scott Chief Operating Officer | 150,000 | $0 | 150,000 (Direct) | View |
Ownership | 2024-04-03 5:19 pm | 2022-08-01 2032-07-10 | Cadrenal Therapeutics Inc. | CVKD | Cole Jeffrey Scott Chief Operating Officer | 0 | $0 | 200,000 (Direct) | View |
2023-10-23 Gift | 2024-02-12 9:41 pm | N/A N/A | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X CEO and Chairman 10% Owner | 85,000 | $0 | 6,325,000 (Direct) | View |
2024-01-18 Option Award | 2024-01-19 7:41 pm | N/A 2034-01-17 | Cadrenal Therapeutics Inc. | CVKD | Zelenkofske Steven Director | 100,000 | $0 | 100,000 (Direct) | View |
2024-01-18 Option Award | 2024-01-19 7:41 pm | N/A 2034-01-17 | Cadrenal Therapeutics Inc. | CVKD | MURPHY JOHN RAYMOND Director | 100,000 | $0 | 100,000 (Direct) | View |
2024-01-18 Option Award | 2024-01-19 7:41 pm | N/A 2034-01-17 | Cadrenal Therapeutics Inc. | CVKD | Lisicki Robert Director | 50,000 | $0 | 50,000 (Direct) | View |
2024-01-18 Option Award | 2024-01-19 7:40 pm | N/A 2034-01-17 | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X Chief Executive Officer 10% Owner | 150,000 | $0 | 150,000 (Direct) | View |
2024-01-18 Option Award | 2024-01-19 7:39 pm | N/A 2034-01-17 | Cadrenal Therapeutics Inc. | CVKD | Szot Matthew K Chief Financial Officer | 250,000 | $0 | 250,000 (Direct) | View |
2024-01-18 Option Award | 2024-01-19 7:38 pm | N/A 2034-01-17 | Cadrenal Therapeutics Inc. | CVKD | WILSON GLYNN Director | 70,000 | $0 | 70,000 (Direct) | View |
2024-01-18 Option Award | 2024-01-19 7:38 pm | N/A 2034-01-17 | Cadrenal Therapeutics Inc. | CVKD | LOSORDO DOUGLAS W Chief Medical Officer | 150,000 | $0 | 150,000 (Direct) | View |
2023-07-23 Option Award | 2023-07-24 5:26 pm | 2024-08-01 2033-07-23 | Cadrenal Therapeutics Inc. | CVKD | Lisicki Robert Director | 75,000 | $0 | 75,000 (Direct) | View |
Ownership(A) | 2023-03-31 06:16 am | 2022-10-01 2032-08-17 | Cadrenal Therapeutics Inc. | CVKD | LOSORDO DOUGLAS W Chief Medical Officer | 0 | $0 | 300,000 (Direct) | View |
2023-02-10 Option Award | 2023-02-13 09:00 am | N/A N/A | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X CEO and Chairman 10% Owner | 25,000 | $1.94 | 6,300,000 (Direct) | View |
2023-01-24 Conversion | 2023-01-24 5:02 pm | N/A N/A | Cadrenal Therapeutics Inc. | CVKD | WILSON GLYNN Director | 50,000 | $0 | 50,000 (Direct) | View |
2023-01-24 Option Award | 2023-01-24 5:01 pm | N/A N/A | Cadrenal Therapeutics Inc. | CVKD | Szot Matthew K Chief Financial Officer | 50,000 | $0 | 500,000 (Direct) | View |
2023-01-24 Conversion | 2023-01-24 5:00 pm | N/A N/A | Cadrenal Therapeutics Inc. | CVKD | MURPHY JOHN RAYMOND Director | 514,792 | $0 | 554,792 (Direct) | View |
Ownership | 2023-01-19 8:31 pm | N/A N/A | Cadrenal Therapeutics Inc. | CVKD | Zelenkofske Steven Director | 0 | $0 | 90,000 (Direct) | View |
Ownership | 2023-01-19 8:29 pm | 2023-10-03 2032-10-02 | Cadrenal Therapeutics Inc. | CVKD | WILSON GLYNN Director | 0 | $0 | 100,000 (Direct) | View |
Ownership | 2023-01-19 8:26 pm | N/A N/A | Cadrenal Therapeutics Inc. | CVKD | Szot Matthew K Chief Financial Officer | 0 | $0 | 450,000 (Direct) | View |
Ownership | 2023-01-19 8:23 pm | N/A N/A | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X CEO and Chairman 10% Owner | 0 | $0 | 6,275,000 (Direct) | View |
Ownership | 2023-01-19 8:20 pm | N/A N/A | Cadrenal Therapeutics Inc. | CVKD | MURPHY JOHN RAYMOND Director | 0 | $0 | 664,792 (Direct) | View |
Ownership | 2023-01-19 8:18 pm | 2023-08-18 2032-08-17 | Cadrenal Therapeutics Inc. | CVKD | LOSORDO DOUGLAS W Chief Medical Officer | 0 | $0 | 300,000 (Direct) | View |